![Robert Gagnon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Gagnon
Directeur Financier/CFO chez
OPUS GENETICS, INC.
Fortune : 3 M $ au 31/10/2026
Profil
Mr. Robert E.
Gagnon is a Chief Financial & Accounting Officer at Opus Genetics, Inc., an Independent Director at Harvard Bioscience, Inc., an Independent Director at Bone Biologics Corp., an Independent Director at Purple Biotech Ltd. and a Secretary, Treasurer & Director at KD Scientific, Inc. He is on the Board of Directors at Harvard Bioscience, Inc., Bone Biologics Corp., Purple Biotech Ltd. and KD Scientific, Inc. Mr. Gagnon was previously employed as a Chief Financial Officer by Remix Therapeutics, Inc., a Partner by Gurnet Point Capital LLC, a Chief Financial & Business Officer by Verastem, Inc., a Chief Financial Officer by Harvard Bioscience, Inc., a Manager-Research & Development by Zimmer Biomet, Inc., a Chief Financial Officer, Treasurer & Executive VP by Clean Harbors, Inc., and a CAO, VP-Business Planning & Controller by Biogen Idec, Inc. He also served on the board at Verastem, Inc. He received his undergraduate degree from Bentley University and an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OPUS GENETICS, INC. 0,65 % | 23/10/2026 | 542 375 ( 0,65 % ) | 2 M $ | 31/10/2026 |
VERASTEM, INC. 0,05 % | 24/03/2026 | 41 678 ( 0,05 % ) | 406 361 $ | 31/10/2026 |
HARVARD BIOSCIENCE, INC. 0,24 % | 09/06/2026 | 11 000 ( 0,24 % ) | 97 900 $ | 31/10/2026 |
PURPLE BIOTECH LTD. 0,09 % | 18/03/2026 | 3 062 500 ( 0,09 % ) | 9 739 $ | 31/10/2026 |
BONE BIOLOGICS CORP. -.--% | 28/09/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
Postes actifs de Robert Gagnon
| Sociétés | Poste | Début |
|---|---|---|
| OPUS GENETICS, INC. | Directeur Financier/CFO | 02/09/2025 |
| PURPLE BIOTECH LTD | Directeur/Membre du Conseil | 03/03/2021 |
| BONE BIOLOGICS CORPORATION | Directeur/Membre du Conseil | 08/01/2024 |
| HARVARD BIOSCIENCE, INC. | Directeur/Membre du Conseil | 16/07/2025 |
KD Scientific, Inc.
 KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Directeur/Membre du Conseil | - |
Anciens postes connus de Robert Gagnon
| Sociétés | Poste | Fin |
|---|---|---|
| VERASTEM, INC. | Directeur/Membre du Conseil | 21/05/2026 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Directeur Financier/CFO | 30/06/2025 |
Gurnet Point Capital LLC
 Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Corporate Officer/Principal | 01/06/2023 |
| VERASTEM, INC. | Directeur Financier/CFO | 31/10/2022 |
| ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Robert Gagnon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Clean Harbors, Inc.
 Clean Harbors, Inc. Environmental ServicesIndustrial Services Provides environmental and industrial waste recycling services | Industrial Services |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Harvard Bioscience, Inc.
 Harvard Bioscience, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets apparatus and scientific instruments | Health Technology |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology Develops and manufactures syringe pumps used by research laboratory markets globally | Health Technology |
Bentley University
 Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verastem, Inc.
 Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bone Biologics Corp.
 Bone Biologics Corp. Medical SpecialtiesHealth Technology Develops ortho biologic products | Health Technology |
Gurnet Point Capital LLC
Gurnet Point Capital LLC Investment ManagersFinance Gurnet Point Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technologies sector. It provides financing for buyout stage capital requirements. It also acquires majority stake and control positions. | Finance |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company develops molecule therapies to modulate RNA processing and address the underlying drivers of diseases | Health Technology |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
Zimmer Biomet, Inc. |
